Papers

18

Total Citations

308

H-Index

9

About

Dr. Naif A. Aldhaam is a leading urologic surgeon and researcher whose work centers on advancing robot-assisted radical cystectomy (RARC) for bladder cancer. His major contributions, largely through the International Robotic Cystectomy Consortium (IRCC), have clarified critical debates in the field. He demonstrated that intracorporeal urinary diversion offers comparable perioperative outcomes to extracorporeal techniques (89 citations) and provided landmark ten-year oncologic data confirming RARC’s long-term efficacy (70 citations). Dr. Aldhaam also showed that neoadjuvant chemotherapy does not increase perioperative morbidity, advocating for its broader use (26 citations), and validated the ACS NSQIP risk calculator for RARC (21 citations). His work extends to optimizing recovery through multidisciplinary rehabilitation pathways and analyzing communication challenges in robotic surgery. With over 280 total citations, Dr. Aldhaam’s research has directly shaped evidence-based guidelines and surgical practice, making him a key voice in the evolution of minimally invasive bladder cancer surgery.

Research Focus

Key Achievements

9
H-Index
18
Papers
308
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
A comparative propensity score‐matched analysis of perioperative outcomes of intracorporeal vs extracorporeal urinary diversion after robot‐assisted radical cystectomy: results from the International Robotic Cystectomy Consortium
89 citations · 2020
📈 Most Prolific Year: 2019 (7 Papers)
🤝 Key Collaborators: 93
🏛 Institutions: Roswell Park Comprehensive Cancer Center, King Fahd Medical City

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago